24小时热门版块排行榜    

查看: 164  |  回复: 20
【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 txh5881 的 71 个金币 ,回帖就立即获得 1 个金币,每人有 1 次机会

txh5881

银虫 (著名写手)


[交流] Postdoctoral fellow in Medicinal Chemistry, McGill University

Postdoctoral fellow in Medicinal Chemistry, McGill University.  

Project description:

This funded project is to develop novel inhibitors of emerging drug targets for lung cancer.  Our preliminary work has discovered initial hits, which show selective cytotoxicity against a panel of lung cancer cell lines, with no obvious toxic effects on normal cells. As a key member of our team, the candidate is expected to chemically optimize the initial active compounds (i.e., Hit-to-Lead Optimization). Our laboratory includes three components: Structure-based Drug Design, Medicinal Chemistry and Biological Assays, providing a multidisciplinary environment. We routinely utilize structure-based drug design approaches for hit identification and optimization. The candidate will have the opportunity to be trained in Structure-based Drug Design.



Qualifications:
We are looking for a candidate who is interested in anticancer drug discovery and determines to develop a life-saving drug. The candidate should have a Ph.D. degree in Organic Chemistry/Medicinal Chemistry, which was obtained in 2025 or 2026.     

Language required: English

Contact:
Interested individuals should send a cover letter, updated CV and the coordinates of 2-3 referees to Dr. Jian Hui Wu (email address:  jian.h.wu@mcgill.ca).
回复此楼

» 猜你喜欢

» 抢金币啦!回帖就可以得到:

查看全部散金贴

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

txh5881

银虫 (著名写手)


Postdoctoral fellow in Medicinal Chemistry, McGill University
Postdoctoral fellow in Medicinal Chemistry, McGill University.  

Project description:

This funded project is to develop novel inhibitors of emerging drug targets for lung cancer.  Our preliminary work has discovered initial hits, which show selective cytotoxicity against a panel of lung cancer cell lines, with no obvious toxic effects on normal cells. As a key member of our team, the candidate is expected to chemically optimize the initial active compounds (i.e., Hit-to-Lead Optimization). Our laboratory includes three components: Structure-based Drug Design, Medicinal Chemistry and Biological Assays, providing a multidisciplinary environment. We routinely utilize structure-based drug design approaches for hit identification and optimization. The candidate will have the opportunity to be trained in Structure-based Drug Design.



Qualifications:
We are looking for a candidate who is interested in anticancer drug discovery and determines to develop a life-saving drug. The candidate should have a Ph.D. degree in Organic Chemistry/Medicinal Chemistry, which was obtained in 2025 or 2026.     

Language required: English

Contact:
Interested individuals should send a cover letter, updated CV and the coordinates of 2-3 referees to Dr. Jian Hui Wu (email address:  jian.h.wu@mcgill.ca).
2楼2026-07-28 10:18:11
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

yigeluren

新虫 (初入文坛)



txh5881(金币+1): 谢谢参与
xiexie
19楼2026-07-29 05:33:59
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
简单回复
2026-07-28 11:01   回复  
txh5881(金币+1): 谢谢参与
2026-07-28 11:02   回复  
txh5881(金币+1): 谢谢参与
jiaoxg5楼
2026-07-28 11:06   回复  
txh5881(金币+1): 谢谢参与
2026-07-28 11:27   回复  
txh5881(金币+1): 谢谢参与
jiantu7楼
2026-07-28 11:40   回复  
txh5881(金币+1): 谢谢参与
2026-07-28 12:08   回复  
txh5881(金币+1): 谢谢参与
xiaoshig9楼
2026-07-28 13:59   回复  
txh5881(金币+1): 谢谢参与
tfang10楼
2026-07-28 14:05   回复  
txh5881(金币+1): 谢谢参与
gter_wang11楼
2026-07-28 14:08   回复  
txh5881(金币+1): 谢谢参与
2026-07-28 14:08   回复  
txh5881(金币+1): 谢谢参与
jiantu13楼
2026-07-28 15:21   回复  
xiaoshig14楼
2026-07-28 16:19   回复  
2026-07-28 20:26   回复  
txh5881(金币+1): 谢谢参与
浮云16616楼
2026-07-28 21:27   回复  
txh5881(金币+1): 谢谢参与
发自小木虫手机客户端
bjdxyxy17楼
2026-07-28 21:32   回复  
txh5881(金币+1): 谢谢参与
发自小木虫手机客户端
psylhh18楼
2026-07-28 22:26   回复  
txh5881(金币+1): 谢谢参与
sct7320楼
2026-07-29 11:46   回复  
txh5881(金币+1): 谢谢参与
lymjjh21楼
2026-07-29 21:35   回复  
txh5881(金币+1): 谢谢参与
相关版块跳转 我要订阅楼主 txh5881 的主题更新
普通表情 高级回复 (可上传附件)
信息提示
请填处理意见